These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8393296)

  • 41. Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell lines.
    Eisman JA; Frampton RJ; McLean FJ
    Cell Biochem Funct; 1986 Apr; 4(2):115-22. PubMed ID: 3011306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
    Liel Y; Kraus S; Levy J; Shany S
    Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways.
    Farach-Carson MC; Abe J; Nishii Y; Khoury R; Wright GC; Norman AW
    Am J Physiol; 1993 Nov; 265(5 Pt 2):F705-11. PubMed ID: 8238551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
    Zhao X; Feldman D
    Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specificity of steroid binding in New World primate B95-8 cells with a vitamin D-resistant phenotype.
    Gacad MA; Adams JS
    Endocrinology; 1992 Dec; 131(6):2581-7. PubMed ID: 1446602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3.
    Cheskis B; Lemon BD; Uskokovic M; Lomedico PT; Freedman LP
    Mol Endocrinol; 1995 Dec; 9(12):1814-24. PubMed ID: 8614417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
    Chen TL; Hauschka PV; Cabrales S; Feldman D
    Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
    Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R
    J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
    van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
    Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
    Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
    Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription.
    Ellison TI; Dowd DR; MacDonald PN
    Mol Endocrinol; 2005 Sep; 19(9):2309-19. PubMed ID: 15919723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.
    Hedlund TE; Moffatt KA; Miller GJ
    Endocrinology; 1996 May; 137(5):1554-61. PubMed ID: 8612485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.
    Griffin JE; Zerwekh JE
    J Clin Invest; 1983 Oct; 72(4):1190-9. PubMed ID: 6313754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line.
    Sergeev IN; Rhoten WB
    Endocrinology; 1995 Jul; 136(7):2852-61. PubMed ID: 7789310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ovary: a target organ for 1,25-dihydroxyvitamin D3.
    Dokoh S; Donaldson CA; Marion SL; Pike JW; Haussler MR
    Endocrinology; 1983 Jan; 112(1):200-6. PubMed ID: 6291916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
    Yao J; Kathpalia P; Bushinsky DA; Favus MJ
    J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: relation to c-myc-oncogene and vitamin-D-receptor expression.
    Hulla W; Kállay E; Krugluger W; Peterlik M; Cross HS
    Int J Cancer; 1995 Sep; 62(6):711-6. PubMed ID: 7558419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.